Associate Director, Global HEOR
uniQure
September 02, 2026
Remote friendly (United States)
United States
Market Access
Associate Director, Global HEOR
Key Responsibilities:
- Develop and implement global HEOR strategies/programs to support AMT-130 launch (USA and globally) and optimize market access.
- Collaborate with partners to build patient-access-focused product value propositions.
- Identify HEOR evidence needs/gaps; design and deliver HEOR/RWE studies and tools for relative value and differentiation.
- Use RWD analytics to inform development and key business questions.
- Lead regulatory-grade RWE studies; educate on RWE opportunities in Huntington’s disease.
- Develop COA measurement strategies/plans to support labeling, access, and differentiation.
- Support global HTA submissions; maintain understanding of payer/HTA processes.
- Build and continuously improve health economic models; adapt models for global HTA price/reimbursement with market access teams.
- Develop payer engagement materials (e.g., GVD, AMCP dossier, payer decks); support US payer engagements.
- Deliver “launch-ready” US economic models ahead of market entry.
- Ensure governance/approvals, manage vendors/projects, and deliver on time and quality within budgets.
- Communicate and disseminate HEOR data/results; translate outputs into launch tools (e.g., value decks, field materials).
- Evaluate payer/HTA decisions and apply learnings; drive evidence strategy pull-through.
Qualifications/Skills:
- Advanced degree required (PhD, PharmD, DrPH, ScD, MS, MPH) in Health Economics/Outcomes Research/Epidemiology/Public Health/Pharmacoeconomics or related.
- 4+ years HEOR with PhD, or 6+ years with Master’s.
- Biotech/pharma/consulting or related life sciences experience.
- Strong expertise in HEOR, economic modeling, and real-world evidence.
- Experience with global payer/reimbursement/HTA submissions; regulatory understanding (FDA/EMA).
- Preferred: cost-effectiveness, budget impact, value assessment modeling.
- Ability to influence cross-functional teams and communicate with scientific/clinical/commercial/market access stakeholders.
Location/Travel: Hybrid (Lexington) with ~25% travel.
Key Responsibilities:
- Develop and implement global HEOR strategies/programs to support AMT-130 launch (USA and globally) and optimize market access.
- Collaborate with partners to build patient-access-focused product value propositions.
- Identify HEOR evidence needs/gaps; design and deliver HEOR/RWE studies and tools for relative value and differentiation.
- Use RWD analytics to inform development and key business questions.
- Lead regulatory-grade RWE studies; educate on RWE opportunities in Huntington’s disease.
- Develop COA measurement strategies/plans to support labeling, access, and differentiation.
- Support global HTA submissions; maintain understanding of payer/HTA processes.
- Build and continuously improve health economic models; adapt models for global HTA price/reimbursement with market access teams.
- Develop payer engagement materials (e.g., GVD, AMCP dossier, payer decks); support US payer engagements.
- Deliver “launch-ready” US economic models ahead of market entry.
- Ensure governance/approvals, manage vendors/projects, and deliver on time and quality within budgets.
- Communicate and disseminate HEOR data/results; translate outputs into launch tools (e.g., value decks, field materials).
- Evaluate payer/HTA decisions and apply learnings; drive evidence strategy pull-through.
Qualifications/Skills:
- Advanced degree required (PhD, PharmD, DrPH, ScD, MS, MPH) in Health Economics/Outcomes Research/Epidemiology/Public Health/Pharmacoeconomics or related.
- 4+ years HEOR with PhD, or 6+ years with Master’s.
- Biotech/pharma/consulting or related life sciences experience.
- Strong expertise in HEOR, economic modeling, and real-world evidence.
- Experience with global payer/reimbursement/HTA submissions; regulatory understanding (FDA/EMA).
- Preferred: cost-effectiveness, budget impact, value assessment modeling.
- Ability to influence cross-functional teams and communicate with scientific/clinical/commercial/market access stakeholders.
Location/Travel: Hybrid (Lexington) with ~25% travel.